The Effect of Pomegranate Juice and Sumac Consumption in the Treatment of Outpatients with COVID-19.
Fatemeh ForouzanfarMohammadreza AhmadpoorMostafa Moshirian FarahiAli HadianfarAmirhossein SahebkarHabibollah EsmailyMohsen NematyHassan RakhshandehPublished in: Mediators of inflammation (2022)
Clinical trials of outpatients have limitations such as patients' resilience to post-COVID-19 follow-up. However, the use of pomegranate juice and sumac can be efficacious in reducing COVID-19 symptoms. This trial is registered with IRCT20190406043175N3.
Keyphrases
- coronavirus disease
- sars cov
- clinical trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- phase ii
- respiratory syndrome coronavirus
- climate change
- phase iii
- study protocol
- peritoneal dialysis
- randomized controlled trial
- patient reported outcomes
- open label
- combination therapy
- physical activity
- patient reported